Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Lineage Cell Therapeutics (LCTX) Q4 2022 Earnings
LCTX
9
Mar
Confirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.04
-0.04
-0.03
-0.03
Details
Expected EPS
-0.04
Actual EPS
-0.03
Surprise EPS
0.01
Surprise Percent
+25%
Description
Lineage Cell Therapeutics (LCTX) has reported earnings of -0.03 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login